You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Automated Dynamic Lists for Efficient Electronic Health Record Management
SBC: Clinacuity, Inc Topic: NCIDESCRIPTION (provided by APPLICANT): Medical errors are recognized as the cause of numerous deaths, and even if some are difficult to avoid, many are preventable. Computerized physician order-entry systems with decision support have been proposed to reducethis risk of medication errors, but these systems rely on structured and coded information in the electronic health record (EHR). Unfortunately, ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Rapid, automated, detection of viral and bacterial pathogens causing meningitis
SBC: IDAHO TECHNOLOGY Topic: NIAIDDESCRIPTION (provided by applicant): Meningitis and encephalitis are inflammatory, often infectious, processes of the central nervous system that can result in significant morbidity and mortality. Prompt, appropriate therapy is crucial, but determining theinfectious etiology can be difficult and time-consuming. A wide-range of pathogens can be involved including both bacteria and viruses. Culture ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression
SBC: NAVIGEN, INC. Topic: NIAMSDESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) affects approximately 1.3 million adults in the United States and up to 1.5% of the population worldwide. In its progressive form the disease has debilitating effects including painful inflammation and destruction of the joints. This affliction leads to considerable lost work and disability. A hallmark of the RA inflammatory respon ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Identification of novel small molecule inhibitors of Arf6 for the treatment of va
SBC: NAVIGEN, INC. Topic: NEIDESCRIPTION (provided by applicant): Age-Related Macular Degeneration is the most common cause of legal blindness in people over 60, affecting an estimated 1.6 million patients. Additionally, over 400,000 diabetic Americans are diagnosed each year with vision-threatening retinal edema and/or neovascularization. The main therapeutic strategies that have been successful to date have focused on reduc ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
AccuTemp Sensor: Radiometry based non-invasive continuous core body temperature m
SBC: THERMIMAGE, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Accurate measurement of core body temperature during surgery as well as in critical care is imperative to a positive outcome and ongoing quality of life for patients. Core temperature management of patients during extended anesthesia such as cardio-pulmonary bypass (CPB) surgery is equally important, yet there is no accurate core body measurement device availab ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Reducing Gait Asymmetry in Lower-LImb Amputees Using Real-Time Rehab to Train-to-
SBC: Veristride, Inc. Topic: NICHDDESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project seeks to demonstrate the feasibility of a novel device for rehabilitation in the home environment, by using wireless instrumentation and smartphone technology forfeedback to amputees about their real-time performance in situ. The mission of Veristride is to improve the mobility and quality of life of pers ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Wearable muscle fiber excitation system for preventing blood clot
SBC: GRADIENT BIOMODELING, LLC Topic: NIMHDESCRIPTION (provided by applicant): Schizophrenia is a complex psychiatric disorder with a heterogeneous clinical phenotype. It is probably one of the most costly psychiatric illnesses, yet the development of novel and safe antipsychotics lags behind. Amplifying the actions of endocannabinoids by inhibiting their enzymatic degradation has emerged as an alternative strategy to exploit the endocann ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
HIGHLY CUSTOMIZABLE BLACKROCK MICRO MOLDED ARRAYS (BRMMA)
SBC: BLACKROCK MICROSYSTEMS, INC Topic: NINDSDESCRIPTION (provided by applicant): In the last two decades though the field of neuroprosthetics has gained tremendous momentum through the development of novel architectures for neural interfaces, however, till date there is no device which can be nomenclatured as the gold standard in the field. As a result the research and technology environment at each laboratory is unique and require a high ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Microbial Platform for Accessing Plant Alkaloids
SBC: BLACKROCK MICROSYSTEMS, INC Topic: NINDSDESCRIPTION (provided by applicant): In order to successfully use microelectrode arrays for stimulation in chronic implantation, the neural electrode must have longevity and efficacy. Efficacy of stimulation primarily means injecting enough charge to the targeted tissue to elicit action potentials. However, in doing so, the electrode itself must not (1) degrade, (2) generate harmful substances and ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Non-Invasive Treatment for Uveitis
SBC: ACIONT, INC. Topic: NEIDESCRIPTION (provided by applicant): The aim of this innovative proposal is to commercialize a non-invasive topical product that treats uveitis which is safe and easy to administer. Uveitis is the third leading cause of blindness in the United States. Heretofore, the primary treatment of intermediate and posterior uveitis has been either oral medications (with significant systemic side effects) or ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health